These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31536894)

  • 41. Design, synthesis and biological evaluation of novel 6-substituted pyrrolo [3,2-d] pyrimidine analogues as antifolate antitumor agents.
    Tian C; Wang M; Han Z; Fang F; Zhang Z; Wang X; Liu J
    Eur J Med Chem; 2017 Sep; 138():630-643. PubMed ID: 28711701
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thymidylate synthase inhibition: a structure-based rationale for drug design.
    Costi MP
    Med Res Rev; 1998 Jan; 18(1):21-42. PubMed ID: 9436180
    [TBL] [Abstract][Full Text] [Related]  

  • 43. LY231514, a pyrrolo[2,3-d]pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes.
    Shih C; Chen VJ; Gossett LS; Gates SB; MacKellar WC; Habeck LL; Shackelford KA; Mendelsohn LG; Soose DJ; Patel VF; Andis SL; Bewley JR; Rayl EA; Moroson BA; Beardsley GP; Kohler W; Ratnam M; Schultz RM
    Cancer Res; 1997 Mar; 57(6):1116-23. PubMed ID: 9067281
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human Thymidylate Synthase Inhibitors Halting Ovarian Cancer Growth.
    Ferrari S; Severi L; Pozzi C; Quotadamo A; Ponterini G; Losi L; Marverti G; Costi MP
    Vitam Horm; 2018; 107():473-513. PubMed ID: 29544641
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Highly efficient ligands for dihydrofolate reductase from Cryptosporidium hominis and Toxoplasma gondii inspired by structural analysis.
    Pelphrey PM; Popov VM; Joska TM; Beierlein JM; Bolstad ES; Fillingham YA; Wright DL; Anderson AC
    J Med Chem; 2007 Mar; 50(5):940-50. PubMed ID: 17269758
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Design, synthesis, biological evaluation and X-ray crystal structure of novel classical 6,5,6-tricyclic benzo[4,5]thieno[2,3-d]pyrimidines as dual thymidylate synthase and dihydrofolate reductase inhibitors.
    Zhang X; Zhou X; Kisliuk RL; Piraino J; Cody V; Gangjee A
    Bioorg Med Chem; 2011 Jun; 19(11):3585-94. PubMed ID: 21550809
    [TBL] [Abstract][Full Text] [Related]  

  • 47. X-ray crystal structures of Enterococcus faecalis thymidylate synthase with folate binding site inhibitors.
    Catalano A; Luciani R; Carocci A; Cortesi D; Pozzi C; Borsari C; Ferrari S; Mangani S
    Eur J Med Chem; 2016 Nov; 123():649-664. PubMed ID: 27517810
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biomolecular study of human thymidylate synthase conformer-selective inhibitors: New chemotherapeutic approach.
    El-Mesallamy HO; El Magdoub HM; Chapman JM; Hamdy NM; Schaalan MF; Hammad LN; Berger SH
    PLoS One; 2018; 13(3):e0193810. PubMed ID: 29538414
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structural and Functional Characterization of the Human Thymidylate Synthase (hTS) Interface Variant R175C, New Perspectives for the Development of hTS Inhibitors.
    Pozzi C; Ferrari S; Luciani R; Costi MP; Mangani S
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30959951
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Understanding the molecular mechanism of substrate channeling and domain communication in protozoal bifunctional TS-DHFR.
    Anderson KS
    Protein Eng Des Sel; 2017 Mar; 30(3):253-261. PubMed ID: 28338744
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structure-based design of substituted diphenyl sulfones and sulfoxides as lipophilic inhibitors of thymidylate synthase.
    Jones TR; Webber SE; Varney MD; Reddy MR; Lewis KK; Kathardekar V; Mazdiyasni H; Deal J; Nguyen D; Welsh KM; Webber S; Johnston A; Matthews DA; Smith WW; Janson CA; Bacquet RJ; Howland EF; Booth CL; Herrmann SM; Ward RW; White J; Bartlett CA; Morse CA
    J Med Chem; 1997 Feb; 40(5):677-83. PubMed ID: 9057854
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Crystal structure of a deletion mutant of human thymidylate synthase Delta (7-29) and its ternary complex with Tomudex and dUMP.
    Almog R; Waddling CA; Maley F; Maley GF; Van Roey P
    Protein Sci; 2001 May; 10(5):988-96. PubMed ID: 11316879
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design, synthesis, anticancer evaluation and docking studies of new pyrimidine derivatives as potent thymidylate synthase inhibitors.
    Amin LHT; Shawer TZ; El-Naggar AM; El-Sehrawi HMA
    Bioorg Chem; 2019 Oct; 91():103159. PubMed ID: 31382056
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Kinetic characterization of bifunctional thymidylate synthase-dihydrofolate reductase (TS-DHFR) from Cryptosporidium hominis: a paradigm shift for ts activity and channeling behavior.
    Atreya CE; Anderson KS
    J Biol Chem; 2004 Apr; 279(18):18314-22. PubMed ID: 14966126
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Binding of the anticancer drug ZD1694 to E. coli thymidylate synthase: assessing specificity and affinity.
    Rutenber EE; Stroud RM
    Structure; 1996 Nov; 4(11):1317-24. PubMed ID: 8939755
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and evaluation of a classical 2,4-diamino-5-substituted-furo[2,3-d]pyrimidine and a 2-amino-4-oxo-6-substituted-pyrrolo[2,3-d]pyrimidine as antifolates.
    Gangjee A; Yang J; McGuire JJ; Kisliuk RL
    Bioorg Med Chem; 2006 Dec; 14(24):8590-8. PubMed ID: 16990006
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selective peptide inhibitors of bifunctional thymidylate synthase-dihydrofolate reductase from Toxoplasma gondii provide insights into domain-domain communication and allosteric regulation.
    Landau MJ; Sharma H; Anderson KS
    Protein Sci; 2013 Sep; 22(9):1161-73. PubMed ID: 23813474
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Crystal structure of the active form of native human thymidylate synthase in the absence of bound substrates.
    Deschamps P; Réty S; Bareille J; Leulliot N
    Acta Crystallogr F Struct Biol Commun; 2017 Jun; 73(Pt 6):336-341. PubMed ID: 28580921
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis of classical, four-carbon bridged 5-substituted furo[2,3-d]pyrimidine and 6-substituted pyrrolo[2,3-d]pyrimidine analogues as antifolates.
    Gangjee A; Zeng Y; McGuire JJ; Kisliuk RL
    J Med Chem; 2005 Aug; 48(16):5329-36. PubMed ID: 16078850
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cyclic Peptides Acting as Allosteric Inhibitors of Human Thymidylate Synthase and Cancer Cell Growth.
    Pacifico S; Santucci M; Luciani R; Saxena P; Linciano P; Ponterini G; Lauriola A; D'Arca D; Marverti G; Guerrini R; Costi MP
    Molecules; 2019 Sep; 24(19):. PubMed ID: 31561530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.